Medical Biology Division 2020

Hsiao, Michael

  • Pikatan NW, Liu YL, Bamodu OA, Hsiao M, Hsu WM, Haryana SM, Sutaryo S , Chao TY, Yeh CT, 2020, “Aberrantly expressed Bruton’s tyrosine kinase preferentially drives metastatic and stem cell-like phenotypes in neuroblastoma cells”, Cellular Oncology, 43(6):1067-1084. (SCIE) (IF: 5.304; SCIE ranking: 23%,27.2%,11.5%)
  • Chang YX, Lin YF, Chen CL, Huang MS, Hsiao M, Liang PH, 2020, “Chaperonin-Containing TCP-1 Promotes Cancer Chemoresistance and Metastasis through the AKT-GSK3β-β-catenin and XIAP-Survivin Pathways”, Cancers, In Press. (SCIE) (IF: 6.126; SCIE ranking: 46.2%,84.8%)
  • Chan MH, Chan YC, Liu RS, Hsiao M*, 2020, “A selective drug delivery system based on phospholipid-type nanobubbles for lung cancer therapy”, Nanomedicine, Oct 28 E-pub. (SCIE) (IF: 4.3; SCIE ranking: 19.2%,41.7%)
  • Hung CC, Zhen YY, Niu SW, Hsu JF, Huang LT, Chuang HH, Wang PH, Lin PC, Lee SC, Chiu YW; Wu CH, Huang MH, Hsiao M, Chen HC, Yang CJ, 2020, “Lung Cancer Cell-Derived Secretome Mediates Paraneoplastic Inflammation and Fibrosis in Kidney in Mice”, Cancers, Novmebr 28; 12, E3561. (SCIE) (IF: 6.126; SCIE ranking: 46.2%,84.8%)
  • Lai TC, Fang CY, Jan YH, Hsieh HL, Yang YF, Liu CY, Chang PM, Hsiao M*, 2020, “Kinase shRNA screening reveals that TAOK3 enhances microtubule-targeted drug resistance of breast cancer cells via the NF-κB signaling pathway”, Cell Communication and Signaling, Oct 21;18(1):164. (SCIE) (IF: 4.344; SCIE ranking: 46.2%,84.8%)
  • Fang CY, Lai TC, Hsiao M*, Chang YC, 2020, “The Diverse Roles of TAO Kinases in Health and Diseases”, International Journal of Molecular Sciences, Oct 10;21(20): 7463. (SCIE) (IF: 4.556; SCIE ranking: 46.2%,84.8%)
  • Wen YC, Lin YW, Chu CY, Yang YC, Yang SF, Liu YF, Hsiao M, Lee WJ, Chien MH, 2020, “Melatonin-triggered post-transcriptional and post-translational modifications of ADAMTS1 coordinately retard tumorigenesis and metastasis of renal cell carcinoma”, Journal of Pineal Research, Sep; 69(2):e12668. (SCIE) (IF: 14.528; SCIE ranking: 1.8%,3.7%,4.2%)
  • Chang YC, Chen MH, Yeh CN, Hsiao M*, 2020, “Omics-based Platforms: Current Status and Potential Use for Cholangiocarcinoma [Invited Reviews]”, Biomolecules, Sep 28; 10(10), 1377. (SCIE) (IF: 4.082; SCIE ranking: 46.2%,84.8%)
  • Chuang HH, Hsu JF, Chang HL, Wang PH, Wei PJ, Wu DW, Huang MS, Hsiao M*, Yang CJ, 2020, “Pin1 coordinates HDAC6 upregulation with cell migration in lung cancer cells”, International Journal of Medical Sciences, Sep. 27, 17(17): 2635-2643. (SCIE) (IF: 2.523; SCIE ranking: 30.3%)
  • Lai PL, Chen TC, Feng CY, Lin H, Ng CH, Chen Y, Hsiao M, Lu J, Huang HC, 2020, “Selection of a malignant subpopulation from a colorectal cancer cell line”, Oncology Letters, 20(3),2937-2945. (SCIE) (IF: 2.311; SCIE ranking: 74.6%)
  • Yang YC, Pan KF, Lee WJ, Chang JH, Tan P, Gu CC, Chang WM, Yang SF, Hsiao M, Hua KT, Chien MM, 2020, “Circulating proteoglycan endocan mediates EGFR-driven progression of non-small cell lung cancer”, Cancer Research, Aug 15; 80(16):3292-3304. (SCIE) (IF: 9.727; SCIE ranking: 7.8%)
  • Lin CH, Hsu TI, Chiou PY, Hsiao M, Wang WC, Chen YC, Lin JT, Wang JY, Lin PC, Lin FC, Tseng YK, Cheng HC, Chen CL, Lu PJ, 2020, “Downregulation of STK4 promotes colon cancer invasion/migration through blocking β‐catenin degradation”, Molecular Oncology, Aug 2; 14(10):2574-2588. (SCIE) (IF: 6.574; SCIE ranking: 14.3%)
  • Yang YF, Wang YY, Hsiao M, Lo S, Chang YC, Jan YH, Lai TC, Lee YC, Hsieh YC, Yuan SSF, 2020, “IMPAD1 Functions as a Mitochondrial Electron Transport Inhibitor that Prevents ROS Production and Promotes Lung Cancer Metastasis Through the AMPK-Notch1-HEY1 Pathway”, Cancer Letters, Aug 10; 485:27-37. (SCIE) (IF: 7.36; SCIE ranking: 12.3%)
  • Wu ATH, Srivastava P, Yadav Vijesh K, Tzeng DTW, Iamsaard S, Su ECY, Hsiao M, Liu MC, 2020, “Ovatodiolide, isolated from Anisomeles indica, suppresses bladder carcinogenesis through suppression of mTOR/β-catenin/CDK6 and exosomal miR-21 derived from M2 tumor-associated macrophages”, Toxicology and Applied Pharmacology, Aug 15; 401:115109. (SCIE) (IF: 3.347; SCIE ranking: 33.6%,30.4%)
  • Yang YF, Chang YC, Jan YH, Yang CJ, Huang MS, Hsiao M*, 2020, “Squalene synthase promotes the invasion of lung cancer cells via the osteopontin/ERK pathway”, Oncogenesis, Aug 29; 9(8):78. (SCIE) (IF: 6.119; SCIE ranking: 15.6%)
  • Fan CC, Tsai ST, Yang JC, Chang LC, Chen GY, Sher YP, Wang SC, Hsiao M*, Chang WC, 2020, “EFHD2 Contributes to Non-small Cell Lung Cancer Cisplatin Resistance by the Activation of NOX4-ROS-ABCC1 Axis”, Redox Biology, Jul; 34:101571. (SCIE) (IF: 9.986; SCIE ranking: 6.7%)
  • Lin YW, Wen YC,Chu CY, Tung MC, Yang YC, Hua KT, Pan KF, Hsiao M, Lee WJ, Chien MH, 2020, “Stabilization of ADAM9 by N-α-acetyltransferase 10 protein contributes to promoting progression of androgen-independent prostate cancer”, Cell Death & Disease, Jul 27; 11(7):591. (SCIE) (IF: 6.304; SCIE ranking: 20.5%)
  • Ho CY, Lin YT, Chen HH, Ho WY, Sun GC, Hsiao M, Lu PJ, Cheng PW, Tseng CJ, 2020, “CX3CR1-microglia mediates neuroinflammation and blood pressure regulation in the nucleus tractus solitarii of fructose-induced hypertensive rats”, Journal of Neuroinflammation, Jun 12; 17(1):185. (SCIE) (IF: 5.793; SCIE ranking: 46.2%,84.8%)
  • Chan MH, Huang WT, Wang J, Liu RS, Hsiao M*, 2020, “Next‐Generation Cancer‐Specific Hybrid Theranostic Nanomaterials: MAGE‐A3 NIR Persistent Luminescence Nanoparticles Conjugated to Afatinib for In Situ Suppression of Lung Adenocarcinoma Growth and Metastasis”, Advanced Science, May 6; 7(9):1903741. (SCIE) (IF: 15.84; SCIE ranking: 46.2%,84.8%)
  • Yang YC, Chien MH, Lai TC, Su CY, Jan YH, Hsiao M*, Chen CL, 2020, “Monoamine Oxidase B Expression Correlates with a Poor Prognosis in Colorectal Cancer Patients and Is Significantly Associated with Epithelial-to-Mesenchymal Transition-Related Gene Signatures”, International Journal of Molecular Sciences, Apr 17; 21(8):2813. (SCIE) (IF: 4.556; SCIE ranking: 46.2%,84.8%)
  • Chang YC, Yang YF, Chiou J, Tsai HF, Fang CY, Yang CJ, Chen CL, Hsiao M*, 2020, “Nonenzymatic function of Aldolase A downregulates miR-145 to promote the Oct4/DUSP4/TRAF4 axis and the acquisition of lung cancer stemness”, Cell Death & Disease, Mar 18; 11(3):195. (SCIE) (IF: 6.304; SCIE ranking: 20.5%)
  • Chan YC, Chang YC, Chuang HH, Yang YC, Lin YF, Huang MS, Hsiao M, Yang CJ, Hua KT, 2020, “Overexpression of PSAT1 promotes metastasis of lung adenocarcinoma by suppressing the IRF1-IFNγ axis”, Oncogene, Mar; 39(12):2509-2522. (SCIE) (IF: 7.971; SCIE ranking: 15.9%,7.9%,9.8%,10.7%)
  • Tan KT, Yeh CN, Chang YC, Cheng JH, Fang WL, Yeh YC, Hsu DS, Wu CE, Liu CY, Chang MS, Lu ML, Chen SJ, Yee C, Hsiao M, Chen MH, 2020, “PRKDC: A New Biomarker and drug target for Checkpoint Blockade Immunotherapy”, Journal for ImmunoTherapy of Cancer, Mar; 8(1):e000485. (SCIE) (IF: 10.252; SCIE ranking: 6.6%,6.3%)
  • Chan MH, Hsieh MR, Liu RS, Wei DH, Hsiao M*, 2020, “Magnetically Guided Theranostics: Optimizing Magnetic Resonance Imaging with Sandwich-Like Kaolinite-Based Iron/Platinum Nanoparticles for Magnetic Fluid Hyperthermia and Chemotherapy”, Chemistry of Materials, 32(2) 697-708. (SCIE) (IF: 9.567; SCIE ranking: 9.2%,14.5%)
  • Chen JH, Wu ATH, Bamodu OA, Yadav VK, Chao TY Tzeng YM, Mukhopadhyay D, Hsiao M, Lee JC, 2020, “Ovatodiolide Suppresses Oral Cancer Malignancy by Down-Regulating Exosomal Mir-21/STAT3/β-Catenin Cargo and Preventing Oncogenic Transformation of Normal Gingival Fibroblasts”, Cancers, Jan; 12:56. (SCIE) (IF: 6.126; SCIE ranking: 46.2%,84.8%)
  • Huang WT, Chan MH, Chen X, Hsiao M*, Liu RS, 2020, “Theranostic Nanobubble Encapsulating A Plasmon-enhanced Upconversion Hybrid Nanosystem for Cancer Therapy”, Theranostics, Jan 1;10(2):782-796. (SCIE) (IF: 8.579; SCIE ranking: 7.2%)

Hsieh, Shie-Liang

  • Hsieh SL, 2020, Lectin in Host Defense Against Microbial Infections, Advances in Experimental Medicine and Biology, 230 pages, Singapore: Springer Nature Singapore Pte Ltd.
  • Sung PS, Chang WC, Hsieh SL*, 2020, “CLEC5A: A Promiscuous Pattern Recognition Receptor to Microbes and Beyond”, editor(s): (Hsieh SL), Lectin in Host Defense Against Microbial Infections, Advances in Experimental Medicine and Biology, pp. 1204: 57-73, 新加坡: Springer Nature Singapore Pte Ltd.

Lee, Wen-Hwa

  • Hsu JL, Chou JW, Chen TF, Hsu JT, Su FY, Lan JL, Wu PC, Hu CM, Lee EY, Lee WH, 2020, “Glutathione peroxidase 8 negatively regulates caspase-4/11 to protect against colitis.”, EMBO Molecular Medicine, 12(1), e9386. (SCI)

Lin, Kuo-I

  • Liao, H.-Y., Wang, S.-C., Ko, Y.-A. Lin, K.-I, Ma, C., Cheng, R. T.-J., and Wong, C.-H., 2020, “Chimeric hemagglutinin vaccine elicits broadly protective CD4 and CD8 T cell responses against multiple influenza strains and subtypes”, Proc Natl Acad Sci USA, 117(30):17757-17763.
  • Chang, Y.-H., Weng, C.-L, and Lin, K.-I*, 2020, “O-GlcNAcylation and its role in the immune system.”, J Biomed Sci., 27(1):57. (SCIE) (IF: 5.762; SCIE ranking: 24.1%,12.2%)
  • Chen, H.-Y., Wu, Y.-F., Chou, F.-C., Wu, Y.-H., Yeh, L.-T., Lin, K.-I, Liu, F.-T., Sytwu, H.-K, 2020, “Intracellular galectin-9 enhances proximal TCR signaling and potentiates autoimmune disease”, JOURNAL OF IMMUNOLOGY, 204(5):1158-1172. (SCIE) (IF: 4.886; SCIE ranking: 28.3%)
  • Liu, C.-H., Chou, C.-T., Chen, C.-H., Chen, C.-H., Yang, S.-Y., Ko, Y.-A., Wu, Y.-T., Wang, C.-C., Liu, F.-C., Yue, C.-T., Hung, S.-C., Tzeng, I-S., Tsai, W.-C. *, and Lin, K.-I*, 2020, “Aberrant distribution and function of plasmacytoid dendritic cells in patients with ankylosing spondylitis are associated with unfolded protein response”, KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, doi: 10.1002/kjm2.12184. (SCIE) (IF: 1.737; SCIE ranking: 77%)

Lu, Joyce Jean

  • Cheng Chih-Lun, Yang Shang-Chih, Lai Chien-Ying, Wang Cheng-Kai, Chang Ching-Fang, Lin Chun-Yu, Chen Wei-Ju, Lin Po-Yu, Wu Han-Chung, Ma Nianhan, Lu Frank Leigh*, Lu Jean*, 2020, “CXCL14 Maintains hESC Self-Renewal through Binding to IGF-1R and Activation of the IGF-1R Pathway”, Cells, 9(7) 1706. (SCIE) (IF: 4.366; SCIE ranking: 46.2%,84.8%)
  • Nguyen Mai-Huong Thi, Lin Chen-Huan, Liu Szu-Mam, Miyashita Azusa, Ihn Hironobu, Lin Hsuan, Ng Chi Hou, Tsai Jen-Chieh, Chen Ming-Hong, Tsai Mu-Shiun, Lin In-Yu, Liu Shu-Chen, Li Long-Yuan, Fukushima Satoshi*, Lu Jean*, Ma Nianhan*, 2020, “miR-524-5p reduces the progression of the BRAF inhibitor-resistant melanoma”, Neoplasia, 22(12) 789-799. (SCIE) (IF: 5.696; SCIE ranking: 19.7%)
  • Lai Pei‑Lun, Chen Ting‑Chun, Feng Chun‑Yen, Lin Hsuan, Ng Chi‑Hou, Chen Yun, Hsiao Michael, Lu Jean*, Huang Hsiao‑Chun*, 2020, “Selection of a malignant subpopulation from a colorectal cancer cell line”, Oncology Letters, 20(3) 2937-2945. (SCIE) (IF: 2.311; SCIE ranking: 74.6%)

Shen, Chia-Ning

  • Chu, E.P.F., C.H.H. Cho, W.J. Lee, I.T.Lee, I.F. Cheng, T.C. Kuo, R.Y. Chen, W.H.H. Sheu, C.N. Shen*, 2020, “Generation of three induced pluripotent stem cell lines from type 2 diabetic patients with ocular complications.”, Stem Cell Research, 49, 102109. (SCIE) (IF: 4.495; SCIE ranking: 34.9%,37.9%,17.9%)
  • Lee, H.L., J.F. Chiou, P.Y. Wang, L.S. Lu, C.N. Shen, H.L. Hsu, T. Burnouf, L.L.Ting, P.C. Chou, C.L. Chung, K.L.Lee, H.S. Shiah, Y.L. Liu, Y.J.Chen*, 2020, “Ex vivo expansion and drug sensitivity profiling of circulating tumor cells from patients with small cell lung cancer”, Cancers, 12(11), 3394. (SCIE) (IF: 6.126; SCIE ranking: 46.2%,84.8%)
  • E.P.F. Chu, C.H. Lin, C.H.H. Cho, I.F. Cheng, T.C. Kuo R.Y. Chen, C.N. Liao, J.C. Cheng, J.I.S. Tsai, P.C. Wang, S.J. Chang, C.N. Shen*, 2020, “Establishment of three human induced pluripotent stem cell lines from a type 1 diabetic family harboring sequence variants associated with autoimmunity”, Stem Cell Research, 49, 102029. (SCIE) (IF: 4.495; SCIE ranking: 34.9%,37.9%,17.9%)
  • Huang, C.Y. L.H. Li ,W.T. Hsu, Y.C. Cheng, M.W. Nicholson, C.L. Liu, C.Y. Ting, H.W. Ko, S.H. Hsu, C.H. Wen, Z. Yan, H.P. Huang, H.L. Su, P.M. Chiang, C.N. Shen, H.F. Chen, B. L.J. Yen, H.E. Lu, S.M. Hwang, S.H. Chiou, H.N. Ho, J.Y. Wu, T. J. Kamp, J.C. Wu and P. C. H. Hsieh*, 2020, “Copy Number Variant Hotspots in Han Taiwanese Population Induced Pluripotent Stem Cell Lines - Lessons from Establishing the Taiwan Human Disease iPSC Consortium Bank”, Journal of Biomedical Science, 27(1), 92. (SCIE) (IF: 5.762; SCIE ranking: 24.1%,12.2%)
  • J.N.Sudhaker, H.H Lu, H.Y. Chang, C.S. Suen, M.J.Hwang, S.Y. Wu, C.N.Shen, Y.M. Chang, F.A. Li, F.T. Liu, and J.W. Shue*, 2020, “Lumenal Galectin-9-Lamp2 interaction regulates lysosome and autophagy to prevent pathogenesis in the intestine and pancreas”, Nature Communications, 11(1), 4286. (SCIE) (IF: 12.121; SCIE ranking: 8.5%)

Yang, Hwai-I

  • Gao X, Yang HI, Trinh H, Jeong D, Li J, Zhang J, Le A, Hoang J, Nguyen P, Henry L, Nguyen MH, 2020, “Antiviral therapy and hepatocellular carcinoma risk in hepatitis B patients with cirrhosis.”, European Journal of Gastroenterology & Hepatology, 32(9),1207-1211. (SCIE) (IF: 2.251; SCIE ranking: 77.3%)
  • Wongjarupong N, Yonli AT, Nagalo BM, Djigma FW, Somda SK, Hassan MA, Mohamed EA, Sorgho AP, Compaore TR, Soubeiga ST, Kiendrebeogo I, Sanou M, Diarra B, Yang HI, Chen CJ, Ouattara AK, Zohoncon TM, Martinson JJ, Buetow K, Chamcheu JC, Antwi SO, Borad MJ, Simpore J, Roberts LR, 2020, “Characteristics of Patients With Chronic Hepatitis B Virus Infection With Genotype E Predominance in Burkina Faso”, Hepatology Communications, 4(12):1781-1792.
  • Petrick JL, Florio AA, Koshiol J, Pfeiffer RM, Yang B, Yu K, Chen CJ, Yang HI, Lee MH, McGlynn KA, 2020, “Prediagnostic concentrations of circulating bile acids and hepatocellular carcinoma risk: REVEAL-HBV and HCV studies.”, INTERNATIONAL JOURNAL OF CANCER, doi: 10.1002/ijc.33051. (SCIE) (IF: 5.145; SCIE ranking: 24.2%)
  • Yang HI*, Yeh ML, Wong GL, Peng CY, Chen CH, Trinh HN, Cheung KS, Xie Q, Su TH, Kozuka R, Lee DH, Ogawa E, Zhao C, Ning HB, Huang R, Li J, Zhang JQ, Ide T, Xing H, Iwane S, Takahashi H, Wong C, Wong C, Lin CH, Hoang J, le A, Henry L, Toyoda H, Ueno Y, Gane EJ, Eguchi Y, Kurosaki M, Wu C, Liu C, Shang J, Furusyo N, Enomoto M, Kao JH, Yuen MF, Yu ML, Nguyen MH*, 2020, “Real-world Effectiveness from the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Oral Antiviral Therapy.”, JOURNAL OF INFECTIOUS DISEASES, 221(3):389-399. (SCIE) (IF: 5.022; SCIE ranking: 25.2%,12%,19.1%)
  • Hsu YC, Wong GL, Chen CH, Peng CY, Yeh ML, Cheung KS, Toyoda H, Huang CF, Trinh H, Xie Q, Enomoto M, Liu L, Yasuda S, Tanaka Y, Kozuka R, Tsai PC, Huang YT, Wong C, Huang R, Jang TY, Hoang J, Yang HI, Li J, Lee DH, Takahashi H, Zhang JQ, Ogawa E, Zhao C, Liu C, Furusyo N, Eguchi Y, Wong C, Wu C, Kumada T, Yuen MF, Yu ML, Nguyen MH, 2020, “Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B.”, The American Journal of Gastroenterology, 115(2), 271-280. (SCIE) (IF: 10.171; SCIE ranking: 8%)
  • Yoshida K, Desbiolles A, Feldman SF, Ahn SH, Alidjinou EK, Atsukawa M, Bocket L, Brunetto MR, Buti M, Carey I, Caviglia GP, Chen EQ, Cornberg M, Enomoto M, Honda M, Zu Siederdissen CH, Ishigami M, Janssen H, Maasoumy B, Matsui T, Matsumoto A, Nishiguchi S, Riveiro-Barciela M, Takaki A, Tangkijvanich P, Toyoda H, van Campenhout MJ, Wang B, Wei L, Yang HI, Yano Y, Yatsuhashi H, Yuen MF, Tanaka E, Lemoine M, Tanaka Y, Shimakawa Y, 2020, “Assay for Hepatitis B Core-related Antigen Identify Patients With High Viral Load: Systematic Review and Meta-analysis of Individual Participant Data.”, CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, pii: S1542-3565(20)30590-5. doi: 10.1016/j.cgh.2020.04.045. (SCIE) (IF: 8.549; SCIE ranking: 11.4%)
  • Li Jie, Yang Hwai-I, Yeh Ming-Lun, Le Michael H, Le An K, Yeo Yee Hui, Dai Chia-Yen, Barnett Scott, Zhang Jian Q, Huang Jee-Fu, Trinh Huy N, Wong Christopher, Wong Clifford, Hoang Joseph K, Cheung Ramsey, Yu Ming-Lung, Nguyen Mindie H, 2020, “Association between fatty liver and cirrhosis, hepatocellular carcinoma, and HBsAg seroclearance in chronic hepatitis B”, The Journal of Infectious Diseases, doi: 10.1093/infdis/jiaa739. (SCIE) (IF: 5.022; SCIE ranking: 25.2%,12%,19.1%)
  • Pan WC*, Yeh SY, Wu CD, Huang YT, Chen YC, Chen CJ, Yang HI*, 2020, “Association between Traffic Count and Cardiovascular Mortality: A Prospective Cohort Study in Taiwan.”, JOURNAL OF EPIDEMIOLOGY, doi: 10.2188/jea.JE20200082. (SCIE) (IF: 3.691; SCIE ranking: 17.6%)
  • Jackson SS, Adami HO, Andreotti G, Beane-Freeman LE, Berrington de Gonzalez A, Buring JE, Fraser GE, Freedman ND, Gapstur SM, Gierach G, Giles GG, Grodstein F, Hartge P, Jenab M, Kirsh V, Knutsen SF, Lan Q, Larsson SC, Lee IM, Lee MH, Liao LM, Milne RL, Monroe KR, Neuhouser ML, O'Brien KM, Petrick JL, Purdue MP, Rohan TE, Sandin S, Sandler DP, Sawada N, Shadyab AH, Simon TG, Sinha R, Stolzenberg-Solomon R, Tsugane S, Weiderpass E, Wolk A, Yang HI, Zheng W, McGlynn KA, Campbell PT, Koshiol J, 2020, “Associations between reproductive factors and biliary tract cancers in women from the Biliary Tract Cancers Pooling Project.”, JOURNAL OF HEPATOLOGY, S0168-8278(20)30292-0. (SCIE) (IF: 20.582; SCIE ranking: 2.3%)
  • Le AK, Yang HI, Yeh ML, Jin M, Trinh HN, Henry L, Liu A, Zhang JQ, Li J, Wong C, Wong C, Cheung R, Yu ML, Nguyen MH, 2020, “Development and validation of a risk score for liver cirrhosis prediction in untreated and treated chronic hepatitis B.”, JOURNAL OF INFECTIOUS DISEASES, jiaa330. (SCIE) (IF: 5.022; SCIE ranking: 25.2%,12%,19.1%)
  • Muhammad Irham Lalu, Chou Wan-Hsuan, Wang Yu-Shiuan, Adikusuma Wirawan, Sung-Ching Wong Henry, Aryani Perwitasari Dyah, Huang Wan-Chen, Chen Ben-Kuen*, Yang Hwai-I*, Chang Wei-Chiao*, 2020, “Evaluation for the Genetic Association between Store-Operated Calcium Influx Pathway (STIM1 and ORAI1) and Human Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection”, BIOLOGY, 9(11) 388.
  • Tanaka Yasuhito, , Ogawa Eiichi, Huang Chung-Feng, Toyoda Hidenori, Jun Dae Won, Tseng Cheng-Hao, Hsu Yao-Chun, Enomoto Masaru, Takahashi Hirokazu, Furusyo Norihiro, Yeh Ming-Lun, Iio Etsuko, Yasuda Satoshi, Lam Carla Pui-Mei, Lee Dong Hyun, Haga Hiroaki, Yoon Eileen L., Ahn Sang Bong, Wong Grace, Nakamuta Makoto, Nomura Hideyuki, Tsai Pei-Chien, Jung Jang Han, Song Do Seon, Dang Hansen, Maeda Mayumi, Henry Linda, Cheung Ramsey, Yuen Man-Fung, Ueno Yoshiyuki, Eguchi Yuichiro, Tamori Akihiro, Yu Ming-Lung, Hayashi Jun, Nguyen Mindie H., 2020, “HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort”, Hepatology International. (SCIE) (IF: 5.102; SCIE ranking: 22.7%)
  • Yeo Yee Hui, Tseng Tai-Chung, Hosaka Tetsuya, Cunningham Chris, Fung James Yan Yue, Ho Hsiu J., Kwak Min-Sun, Trinh Huy N., Ungtrakul Teerapat, Yu Ming-Lung, Kobayashi Mariko, Le An K., Henry Linda, Li Jiayi, Zhang Jian, Sriprayoon Tassanee, Jeong Donghak, Tanwandee Tawesak, Gane Ed, Cheung Ramsey C., Wu Chun-Ying, Lok Anna S., Lee Hyo-Suk, Suzuki Fumitaka, Yuen Man-Fung, Kao Jia-Horng, Yang Hwai-I, Nguyen Mindie H., 2020, “Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients”, Clinical and Translational Gastroenterology, 11(9):e00196. (SCIE) (IF: 3.968; SCIE ranking: 36.4%)
  • Liu Zhiwei, Derkach Andriy, Yu Kelly J., Yeager Meredith, Chang Yu-Sun, Chen Chien-Jen, Gyllensten Ulf, Lan Qing, Lee Mei-Hsuan, McKay James D., Rothman Nathaniel, Yang Hwai-I, Hildesheim Allan, Pfeiffer Ruth M., 2020, “Patterns of Human Leukocyte Antigen Class I and Class II Associations and Cancer”, Cancer Research, canres.2292.2020. (SCIE) (IF: 9.727; SCIE ranking: 7.8%)
  • Polaris Observatory Collaborators, 2020, “The case for simplifying and using absolute targets for viral hepatitis elimination goals”, Journal of Viral Hepatitis, doi: 10.1111/jvh.13412. (SCIE) (IF: 3.561; SCIE ranking: 43.2%,33.7%,35.1%)